• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结肠黏液腺癌阴性淋巴结/T分期比值对数优势比的递归划分分期系统。

Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma.

作者信息

Cai Huajun, Zeng Jintao, Wang Ye, Zhuang Jinfu, Liu Xing, Guan Guoxian

机构信息

Department of Colorectal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

出版信息

Front Immunol. 2024 Dec 20;15:1472620. doi: 10.3389/fimmu.2024.1472620. eCollection 2024.

DOI:10.3389/fimmu.2024.1472620
PMID:39759511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695370/
Abstract

BACKGROUND

This study aimed to investigate the prognostic significance of the log odds of negative lymph nodes/T stage ratio (LONT) and develop an efficient prognostic staging system using LONT in patients with colon mucinous adenocarcinoma (MAC).

METHODS

This study included 5,236 patients diagnosed with colon MAC obtained from the Surveillance, Epidemiology, and End Results database. The Kaplan-Meier method, subgroup analysis, receiver operating characteristic (ROC) curve, and Cox proportional hazard regression model were used to determine the clinical outcomes. Recursive partitioning analysis (RPA) was used to develop a novel prognostic system.

RESULTS

The 1-, 3-, and 5-year ROC curves, used to predict cancer-specific survival (CSS) and overall survival (OS), demonstrated that the areas under the ROC curve for LONT were superior to those of pT, pN, and pTNM stages. Additionally, a lower LONT was correlated with worse clinical outcomes. The LONT classification efficiently differentiated the prognosis of patients in terms of OS and CSS. Multivariate Cox analyses revealed that LONT was an independent prognostic factor for both CSS and OS. Based on the pT stage and LONT, a novel prognostic staging system was developed using RPA, demonstrating a good prognostic predictive performance.

CONCLUSION

A lower LONT was associated with worse survival in patients with colon MAC. The pT stage and LONT-based prognostic staging system facilitated risk stratification in these patients.

摘要

背景

本研究旨在探讨阴性淋巴结对数/T分期比值(LONT)的预后意义,并开发一种使用LONT的高效预后分期系统,用于结肠黏液腺癌(MAC)患者。

方法

本研究纳入了5236例从监测、流行病学和最终结果数据库中获取的诊断为结肠MAC的患者。采用Kaplan-Meier法、亚组分析、受试者工作特征(ROC)曲线和Cox比例风险回归模型来确定临床结局。采用递归划分分析(RPA)开发一种新的预后系统。

结果

用于预测癌症特异性生存(CSS)和总生存(OS)的1年、3年和5年ROC曲线显示,LONT的ROC曲线下面积优于pT、pN和pTNM分期。此外,较低的LONT与较差的临床结局相关。LONT分类在OS和CSS方面有效地分化了患者的预后。多变量Cox分析显示,LONT是CSS和OS的独立预后因素。基于pT分期和LONT,使用RPA开发了一种新的预后分期系统,显示出良好的预后预测性能。

结论

较低的LONT与结肠MAC患者较差的生存相关。基于pT分期和LONT的预后分期系统有助于对这些患者进行风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/3ff19443c925/fimmu-15-1472620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/e5825c54256d/fimmu-15-1472620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/04a17ac35263/fimmu-15-1472620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/5cc3b71b8842/fimmu-15-1472620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/b97fe29afac5/fimmu-15-1472620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/3ff19443c925/fimmu-15-1472620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/e5825c54256d/fimmu-15-1472620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/04a17ac35263/fimmu-15-1472620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/5cc3b71b8842/fimmu-15-1472620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/b97fe29afac5/fimmu-15-1472620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg

相似文献

1
Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma.基于结肠黏液腺癌阴性淋巴结/T分期比值对数优势比的递归划分分期系统。
Front Immunol. 2024 Dec 20;15:1472620. doi: 10.3389/fimmu.2024.1472620. eCollection 2024.
2
Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.淋巴结阳性对数优势在结直肠黏液腺癌预后评估中的价值:分析及外部验证。
Cancer Med. 2021 Dec;10(23):8542-8557. doi: 10.1002/cam4.4366. Epub 2021 Nov 18.
3
Nomogram based on the log odds of negative lymph node/T stage can predict the prognosis of patients with colorectal cancer: a retrospective study based on SEER database and external validation in China.基于阴性淋巴结/肿瘤分期对数概率的列线图可预测结直肠癌患者的预后:一项基于SEER数据库的回顾性研究及在中国的外部验证
BMJ Open. 2024 Dec 20;14(12):e083942. doi: 10.1136/bmjopen-2024-083942.
4
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.淋巴结/肿瘤分期阴性的对数比值:一种新的可预测和预后工具,用于评估可切除胃癌患者。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2259-2269. doi: 10.1007/s00432-021-03654-y. Epub 2021 May 18.
5
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.阴性淋巴结对数比值/T分期作为根治性膀胱切除术后膀胱癌患者新的预后因素的预测价值。
Front Oncol. 2022 Jul 19;12:895413. doi: 10.3389/fonc.2022.895413. eCollection 2022.
6
Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.淋巴结/肿瘤分期比值的对数值(LONT):用于评估 55 岁及以上无远处转移分化型甲状腺癌患者的新预后工具。
Front Endocrinol (Lausanne). 2023 Mar 22;14:1132687. doi: 10.3389/fendo.2023.1132687. eCollection 2023.
7
Survival Benefits of Postoperative Chemotherapy in Patients With Colorectal Mucinous Adenocarcinoma: An Analysis Utilizing Propensity Score Matching From the Surveillance, Epidemiology, and End Results Database.术后化疗对结直肠黏液腺癌患者生存获益的影响:基于监测、流行病学和最终结果数据库的倾向评分匹配分析。
Am Surg. 2024 Nov;90(11):2969-2984. doi: 10.1177/00031348241257469. Epub 2024 Jun 7.
8
A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.基于阳性淋巴结对数优势比的预后模型预测直肠癌患者的预后。
J Gastrointest Cancer. 2024 Sep;55(3):1111-1124. doi: 10.1007/s12029-024-01046-2. Epub 2024 May 3.
9
Prognostic model for log odds of negative lymph node in locally advanced rectal cancer via interpretable machine learning.基于可解释机器学习的局部晚期直肠癌阴性淋巴结对数优势比的预后模型
Sci Rep. 2025 Mar 7;15(1):7924. doi: 10.1038/s41598-025-90191-0.
10
Construction and validation of a novel nomogram based on the log odds of positive lymph nodes to predict cancer-specific survival in elderly patients with gastric adenocarcinoma after radical surgery.基于阳性淋巴结对数比值构建并验证新型列线图以预测老年胃腺癌患者根治性手术后的癌症特异性生存情况。
BMC Gastroenterol. 2025 Apr 2;25(1):215. doi: 10.1186/s12876-025-03813-2.

引用本文的文献

1
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis.微生物群-癌症轴作为早发性肿瘤发生的一个潜在促成因素。
Med Oncol. 2025 Sep 6;42(10):464. doi: 10.1007/s12032-025-02988-8.
2
Prognostic value of the log odds of negative lymph nodes/T stage ratio (LONT) in postoperative esophageal cancer: a SEER-based study.阴性淋巴结/肿瘤分期比值(LONT)的对数优势比在食管癌术后的预后价值:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2025 Aug 20;15:1619106. doi: 10.3389/fonc.2025.1619106. eCollection 2025.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Finding the minimum number of retrieved lymph nodes in node-negative colorectal cancer using Real-world Data and the SEER database.利用真实世界数据和 SEER 数据库寻找结阴性结直肠癌中最少检出的淋巴结数量。
Int J Surg. 2023 Dec 1;109(12):4173-4184. doi: 10.1097/JS9.0000000000000746.
3
Optimal examined lymph node number for accurate staging and long-term survival in rectal cancer: a population-based study.
直肠癌准确分期和长期生存的最佳检查淋巴结数:一项基于人群的研究。
Int J Surg. 2023 Aug 1;109(8):2241-2248. doi: 10.1097/JS9.0000000000000320.
4
Colorectal mucinous adenocarcinoma indicates a meaningful subtype: A whole genome sequencing study.结直肠黏液腺癌是一种有意义的亚型:一项全基因组测序研究。
Clin Transl Med. 2023 Apr;13(4):e1246. doi: 10.1002/ctm2.1246.
5
Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.淋巴结/肿瘤分期比值的对数值(LONT):用于评估 55 岁及以上无远处转移分化型甲状腺癌患者的新预后工具。
Front Endocrinol (Lausanne). 2023 Mar 22;14:1132687. doi: 10.3389/fendo.2023.1132687. eCollection 2023.
6
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis.基于递归分区分析的初治转移性鼻咽癌的预后亚组和辅助局部区域放疗的临床决策制定:一项回顾性研究。
Radiat Oncol. 2023 Jan 21;18(1):15. doi: 10.1186/s13014-022-02168-2.
7
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.阴性淋巴结对数比值/T分期作为根治性膀胱切除术后膀胱癌患者新的预后因素的预测价值。
Front Oncol. 2022 Jul 19;12:895413. doi: 10.3389/fonc.2022.895413. eCollection 2022.
8
Prognostic and Predictive Model of the Log Odds of the Negative Lymph Node/T Stage Ratio in Resectable Gastric Adenocarcinoma Patients.可切除胃腺癌患者阴性淋巴结/肿瘤分期比值的对数比值的预后和预测模型。
J Gastrointest Surg. 2022 Aug;26(8):1743-1756. doi: 10.1007/s11605-022-05408-8. Epub 2022 Jul 14.
9
Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in locally recurrent nasopharyngeal carcinoma patients.基于递归分割分析的局部复发鼻咽癌患者再放疗指导预后模型的建立与验证。
Radiother Oncol. 2022 Mar;168:61-68. doi: 10.1016/j.radonc.2022.01.026. Epub 2022 Jan 29.
10
Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.黏液腺癌:结直肠癌中一种独特的临床病理亚型。
World J Gastrointest Surg. 2021 Dec 27;13(12):1567-1583. doi: 10.4240/wjgs.v13.i12.1567.